Skip to content

IPD base Ayurvedic managment for amavata

Multidimentional complex ayurvedic management of amavata (rheumatoid arthritis)- a single group pre post designed clinical study on amavata

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041586
Enrollment
20
Registered
2022-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z00-Z99- Factors influencing health status and contact with health services Health Condition 2: M95-M95- Other disorders of the musculoskeletal system and connective tissue Health Condition 3: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Sponsors

J S ayurveda mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients will be diagnosed with Amavata (Rheumatoid Arthritis) with the help of presence of signs and symptoms like Sandhishula (pain in joints), Sandhijadyata (stiffness in joints), Sandhisotha (swelling in joints), Restriction of movement. All the patients who diagnosed as an amavata will also be screened by the parameters of 2010 ACR-EULAR RA classification criteria for the diagnosis of rheumatoid arthritis.

Exclusion criteria

Exclusion criteria: 1. Patients who have developed complications of rheumatoid arthritis e.g. severe deformity of joints, bones, pleura-pericardial disease or else. 2. Association of joint disease of other origin. 3. Patients on prolonged medication with immunosuppressive e.g. corticosteroids, any other drugs within last 6 months that may have influence on the outcome of the study. 4. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
to find out the changes in grade-score of VAS scale of joint pain and signs and symptoms of amavata by recording them before and after the administration of treatmentTimepoint: Baseline and after 4 weeks

Secondary

MeasureTime frame
nillTimepoint: not applicable

Countries

India

Contacts

Public ContactDr Jagruti R Kokani

J.S.ayurveda mahavidhyalaya

manishayu97@yahoo.com9979589865

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026